Clinical Trials Logo

Clinical Trial Summary

Data on neonatal GBS disease are very limited in China. Acceptance and implementation of prevention measures such as antibiotics prevention or vaccination against GBS disease would require robust data. This study as the first national, multicenter study to investigate the epidemiology of GBS disease in China, and the resistance surveillance of GBS isolates, to appraise the necessity of appropriate interventions.


Clinical Trial Description

n/a


Study Design

Observational Model: Case-Only, Time Perspective: Prospective


Related Conditions & MeSH terms

  • Invasive Group B Streptococcal Disease

NCT number NCT02812576
Study type Observational
Source Health Science Center of Xi’an Jiaotong University
Contact Wenjing Ji, MS
Phone 86+29+82655132
Email yfyx_8312@163.com
Status Recruiting
Phase N/A
Start date May 2016
Completion date December 2017

See also
  Status Clinical Trial Phase
Completed NCT01933646 - Burden of Invasive Group B Streptococcal (GBS) Disease in Young Infants in China N/A
Active, not recruiting NCT01911572 - Genetic Susceptibility to Severe Streptococcal Infections